{
  "created_at": "Tue Jun 07 22:25:10 +0000 2022",
  "id_str": "1534286612179329024",
  "full_text": "Experts advising the FDA endorsed Novavax’s Covid-19 vaccine, voting overwhelmingly that the shot’s benefits outweighed its risks. The agency is expected to next decide on authorizing the shot. https://t.co/JNy5TgcSIh",
  "display_text_range": [
    0,
    217
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/JNy5TgcSIh",
        "expanded_url": "https://on.wsj.com/3NycY4E",
        "display_url": "on.wsj.com/3NycY4E",
        "indices": [
          194,
          217
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 40,
  "favorite_count": 88,
  "possibly_sensitive": false,
  "original_created_at": "Tue Jun 07 21:30:08 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "FDAに助言する専門家は、ノババックスのCovid-19ワクチンを支持し、この注射の利点がそのリスクを上回ると圧倒的に票を投じた。FDAは次にこの注射の認可を決定する予定である。https://t.co/JNy5TgcSIh"
    },
    {
      "locale": "zh",
      "full_text": "为美国食品和药物管理局提供建议的专家认可了Novavax公司的Covid-19疫苗，并以压倒性的票数认为该疫苗的好处超过了风险。预计该机构下一步将决定是否批准该疫苗。https://t.co/JNy5TgcSIh"
    },
    {
      "locale": "zh-Hant",
      "full_text": "爲美國食品和藥物管理局提供建議的專家認可了Novavax公司的Covid-19疫苗，並以壓倒性的票數認爲該疫苗的好處超過了風險。預計該機構下一步將決定是否批准該疫苗。https://t.co/JNy5TgcSIh"
    }
  ]
}